Schoch Charles
SEC CIK 2007349 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| CADL | Candel Therapeutics, Inc. | See Remarks | 43.4K | — | $311.9K | 6 | 2024-07-11 | 2025-06-25 |
Most active insiders at CADL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Tak Paul Peter | CEO, Dir | — | $3.16M |
| 2 | Manning Paul B | Dir | $3.00M | — |
| 3 | Barone Francesca | CSO | — | $235.8K |
| 4 | Tyagarajan Seshu | CTO | — | $154.2K |
Schoch Charles made no open-market trades at CADL in the last 12 months.
Transactions 6
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-06-26 | 2025-06-25 | CADL | Candel Therapeutics, Inc. | Schoch Charles | CFO | A - Grant | $4.67 | +5,353 | 43.4K | +14% | +$25.0K | |
| T | 2025-03-19 | 2025-03-17 | CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | S - Sale | $8.83 | -5,000 | 38.0K | -12% | -$44.1K |
| 2025-01-17 | 2025-01-15 | CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | S - Sale | $7.23 | -9,511 | 43.0K | -18% | -$68.8K | |
| 2025-01-10 | 2025-01-08 | CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | S - Sale | $8.22 | -9,971 | 52.5K | -16% | -$82.0K | |
| 2024-07-19 | 2024-07-17 | CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | S - Sale | $6.47 | -9,884 | 62.5K | -14% | -$63.9K | |
| 2024-07-15 | 2024-07-11 | CADL | Candel Therapeutics, Inc. | Schoch Charles | See Remarks | S - Sale | $5.97 | -8,897 | 72.4K | -11% | -$53.1K |
Purchase Sale Sale after option exercise All abbreviations